Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03298776
Other study ID # STH18011
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 26, 2013
Est. completion date January 5, 2019

Study information

Verified date February 2019
Source Sheffield Teaching Hospitals NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The use of endoscopy for the diagnosis of gastrointestinal diseases has continued to increase in recent years.

Endoscopy provides an advantage over other noninvasive or minimally invasive procedures in that it allows both direct visualisation of the mucosa but direct and accurate sampling of abnormalities for histological examination. However standard endoscopy does have some limitations particularly with small lesions and pan mucosal changes. Some lesions may be entirely benign and require no further intervention but as a result of difficulty with accurate endoscopic characterization of lesions in many cases unnecessary biopsies or polypectomies are undertaken. Therefore any technology that can augment the use of standard endoscopy to minimise unnecessary intervention should be encouraged. IScan is a digital enhancement technique available with Pentax endoscopes. There have been other novel endoscopic advances for example, Narrow band imaging but these have not been adopted widely for a number of reasons including technical difficulties or patient tolerability. The aim of this study is to assess whether Pentax IScan technology is a reliable method of improving our recognition of macroscopic mucosal lesions compared to standard white light endoscopy


Description:

All patients recruited will undergo standard endoscopy using current generation Pentax endoscopes. These endoscopes are widely used for standard endoscopic procedures. All of the endoscopes that will be used have the I-scan function which is controlled by the operator. Therefore there will be no difference between the groups randomised to I-Scan or standard endoscopy, other than a very slight difference in duration for I-scan, which the patient is unlikely to detect. We have received no funding from Pentax for the use of their endoscopes.

Following recruitment patients will be randomly allocated to receive standard white light endoscopy or standard white light endoscopy plus I-Scan using a random number generator at www.random.org with possible values of 0 or 1. Those with a 0 will receive standard endoscopy and those with a 1 will receive standard endoscopy plus I-Scan. Both arms will undergo standard endoscopic evaluation including appropriate biopsies by fully trained experienced endoscopists with Joint Advisory Group (JAG) accreditation for endoscopy. The investigators will be initially blinded to the indication for endoscopy until the I-Scan has been utilised at which point the indication will be revealed to ensure patient safety. Patients will have biopsies only by the clinical indication. No extra biopsies that would not normally be clinically justified will be taken. Following the procedure all patients will be asked to evaluate the tolerability of their test using a validated 10 point likert scale. All procedures will be recorded on an anonymised basis using a unique research identifier and subsequently reviewed by other expert endoscopists within the department to allow us to accurately assess the reliability and interobserver variability of the test. Each of the endoscopists will be fully trained in standard endoscopy and will be blinded to the indication for the procedure.

The study will be a randomised controlled trial. Given the nature of the study it is not possible to blind the investigators to the procedure type. The investigator carrying out the procedure will however be blinded to the indication for the procedure until the I-Scan has been used as this could lead to bias. The endoscopists reviewing the images will be blinded to all patient information and indications for the endoscopy throughout the study period.


Recruitment information / eligibility

Status Completed
Enrollment 758
Est. completion date January 5, 2019
Est. primary completion date August 6, 2018
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- All patients attending for a routine diagnostic endoscopic procedure where Pentax endoscopes are in use at the endoscopy unit at the Royal Hallamshire Hospital.

Exclusion Criteria:

- Patients attending for a therapeutic endoscopic procedure.

- Patients with a known endoscopic diagnosis

- Patients with abnormal coagulation or any other contraindication to use of standard biopsy or polypectomy techniques used in routine diagnostic endoscopic procedures

- Patients who are unable to understand English or give informed consent

- Patients under the age of 16

Study Design


Related Conditions & MeSH terms


Intervention

Device:
I-Scan
I-Scan is a digital enhancement technique. These endoscopes already have greater definition compared to many standard endoscopes but they also utilise a 'zoom' function and digital image enhancement.
Diagnostic Test:
Standard endoscopy
Patients referred for standard endoscopy to receive standard of care only

Locations

Country Name City State
United Kingdom Royal Hallamshire Hospital Sheffield South Yorkshire

Sponsors (1)

Lead Sponsor Collaborator
Sheffield Teaching Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clarity of mucosal lesions found using I-Scan The endoscopic assessment of mucosal lesions using standard endoscopy and standard endoscopy plus I-Scan Will be compared to histological assessment where this is indicated. Interobserver variability of assessment of mucosal lesions will be compared between endoscopic techniques through study completion, on average one year
Secondary Patient reported tolerability of I-scan procedure The use of the I-scan results in a slight prolongation of the endoscopy procedure. A ten point likert patient reported questionnaire will assess patient tolerability of the I-scan through study completion, on average one year
See also
  Status Clinical Trial Phase
Completed NCT02887378 - Protocol for Anatomopathologic Analysis of Biopsies Using Hot Clamps N/A
Recruiting NCT01627171 - Colonoscopy Preparation Optimization for INpatients- COIN Study Phase 4
Completed NCT02350933 - Endoscopic Evaluation of the Paediatric Airway After Prior Prolonged (>24 h) Tracheal Intubation N/A
Completed NCT00671177 - Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique N/A
Completed NCT06033729 - Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA N/A
Withdrawn NCT04983498 - Enhanced Recovery Pathway for Endoscopy Phase 4
Enrolling by invitation NCT04719117 - Retrograde Cholangiopancreatography AI Assisted System Validation on Effectiveness and Safety
Completed NCT03369197 - Nasal Continuous Positive Airway Pressure Versus Standard Care During Procedural Sedation for Gastrointestinal Endoscopy N/A
Completed NCT04186390 - Learning Small Bowel Capsule Endoscopy
Completed NCT02714699 - Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy Phase 2/Phase 3
Completed NCT00614159 - Ketamine Compared to Propofol for Pediatric GI Endoscopy N/A
Completed NCT04072328 - Propofol vs. Midazolam With Propofol for Sedative Endoscopy in Patients With Previous Paradoxical Reaction to Midazolam Phase 2
Completed NCT04150237 - Using Simulation to Ensure Basic Competence in Gastroscopy
Completed NCT03287687 - Safety and Efficacy of CO2 for Endoscopy Phase 4
Not yet recruiting NCT03351790 - Endoscopy Quality Study N/A
Completed NCT04541667 - Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant N/A
Active, not recruiting NCT06168682 - Nasal CPAP - The Treatment IMpact on Oxygenation in High-risk Patients During Deep Sedation for Endoscopy N/A
Recruiting NCT05479253 - AI-assisted Endoscopy Report System In Improving Reporting Quality N/A
Recruiting NCT04903444 - Development and Validation of an Artificial Intelligence-based Biliary Stricture Navigation System in MRCP-based ERCP N/A
Recruiting NCT04809025 - Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer